3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
CNS
1
Conditions
Pancreatic Neoplasms
90
Breast Neoplasms
87
Carcinoma, Non-Small-Cell Lung
33
Triple Negative Breast Neoplasms
22
Squamous Cell Carcinoma of Head and Neck
19
Neoplasms
18
Neoplasm Metastasis
18
Ovarian Neoplasms
17
Stomach Neoplasms
15
Lung Neoplasms
13
Head and Neck Neoplasms
11
Esophageal Squamous Cell Carcinoma
10
Esophageal Neoplasms
10
Cholangiocarcinoma
10
Recurrence
9
Melanoma
8
Small Cell Lung Carcinoma
7
Sarcoma
7
Pancreatic Adenocarcinoma
7
Inflammatory Breast Neoplasms
7
Breast Neoplasms, Male
7
Adenocarcinoma
7
Prostatic Neoplasms
6
Fallopian Tube Neoplasms
6
Urinary Bladder Neoplasms
5
Carcinoma, Ovarian Epithelial
5
Biliary Tract Neoplasms
5
Uterine Cervical Neoplasms
4
Gallbladder Neoplasms
4
Carcinoma, Ductal, Breast
4
Interventions
Temozolomide
264
Radiotherapy
119
Bevacizumab
105
Magnetic Resonance Spectroscopy
59
Radiation
47
pembrolizumab
30
Irinotecan
28
Surgical Procedures, Operative
23
Lomustine
21
Specimen Handling
19
Nivolumab
19
Radiosurgery
18
Carmustine
18
Aminolevulinic Acid
16
Erlotinib Hydrochloride
15
Drug Therapy
15
Blood Specimen Collection
14
Radiotherapy, Intensity-Modulated
13
O(6)-benzylguanine
13
Chemotherapy, Adjuvant
13
Carboplatin
13
Filgrastim
11
Cyclophosphamide
11
sargramostim
10
poly ICLC
10
atezolizumab
10
Thalidomide
10
Etoposide
10
Ipilimumab
9
Everolimus
9
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
OTHER
×
Glioblastoma
×
Albumin-Bound Paclitaxel
×
Clear all
NCT04528680
2026-04-13
SC9/ABX
Northwestern University
Phase 1/2
Active not recruiting
57 enrolled